Race Oncology Secures human ethics trial approval
Race Oncology (RAC) receives human ethics approval for the next stage of its clinical trial of Zantrene...
Race Oncology Appoints Damian Clarke-Bruce as CEO and MD
Race Oncology (RAC) appoints Damian Clarke-Bruce as Managing Director and Chief Executive Officer, effective from...
Race Oncology Reports $1.8m in cash outflows
Race Oncology (RAC) reports $1.8 million in cash outflows for the quarter, an increase from the $931,000...
Race Oncology’s (RAC) preclinical research program has shown the Bisantrene treatment to be an effective chemotherapeutic agent
To test this, sixteen breast cancer...
